OTC · GVDI
Golden Valley Development, Inc
$0.01$0.00 (0.0%)
Golden Valley Development, Inc’s quoted price sits in the lower half of its reported 52-week range, 74.2% below the high.
Loading market information…
OTC · BIEL · USD
Stock price
Quote as of Oct 29, 2026, 06:46 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Bioelectronics Corporation’s quoted price sits in the lower half of its reported 52-week range, 78.57% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE COMPANY BEHIND THE TICKER
BioElectronics Corporation, an electroceutical company, engages in the development and sale of wearable, neuromodulation devices to mitigate neurological diseases and enhance quality of life worldwide. Its products include ActiPatch, a musculoskeletal pain therapy; Allay, a menstrual pain therapy; and Smart Insole, a heel pain therapy. The company also offers RecoveryRx, a medical device that provides pain management therapy for medical professionals; and HealFast, a drug-free therapy for horses, cats, and dogs that reduces swelling and pain, as well as heals muscle and tendon injuries, sores, and incisions. It sells its products to wholesale distributors, hospitals and clinics, and consumers. The company was incorporated in 2000 and is headquartered in Frederick, Maryland.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 10:17 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$0.01$0.00 (0.0%)
Golden Valley Development, Inc’s quoted price sits in the lower half of its reported 52-week range, 74.2% below the high.
CA$0.04CA$0.00 (0.0%)
AI/ML Innovations Inc.’s quoted price sits in the lower half of its reported 52-week range, 52.94% below the high.
£0.02+£0.00 (+15.75%)
Proteome Sciences plc’s quoted price sits in the lower half of its reported 52-week range, 61.59% below the high.
$0.10$0.00 (0.0%)
Chimeric Therapeutics Limited’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
$0.06+$0.02 (+50.0%)
ADM Tronics Unlimited, Inc.’s quoted price sits in the lower half of its reported 52-week range, 50.0% below the high.
CA$0.06+CA$0.01 (+10.0%)
PharmaTher Holdings Ltd.’s quoted price sits in the lower half of its reported 52-week range, 65.63% below the high.
$0.01$0.00 (0.0%)
NuGen Medical Devices Inc.’s quoted price sits in the lower half of its reported 52-week range, 72.3% below the high.
$0.01$0.00 (0.0%)
Odyssey Health, Inc.’s quoted price sits in the lower half of its reported 52-week range, 91.25% below the high.
